Published in Clin Exp Immunol on May 01, 2000
Tularemia. Clin Microbiol Rev (2002) 8.51
Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev (2009) 1.59
Immunity to Francisella. Front Microbiol (2011) 1.37
Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm. Trends Immunol (2003) 1.27
The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis. PLoS One (2010) 1.16
Characterization of lethal inhalational infection with Francisella tularensis in the common marmoset (Callithrix jacchus). J Med Microbiol (2010) 0.94
Regulation and function of IL-17A- and IL-22-producing γδ T cells. Cell Mol Life Sci (2011) 0.91
Differential effects of tumour necrosis factor-alpha and interleukin-12 on isopentenyl pyrophosphate-stimulated interferon-gamma production by cord blood Vgamma9 T cells. Immunology (2008) 0.80
V gamma 9V delta 2 T cells in human legionellosis. Clin Diagn Lab Immunol (2001) 0.79
Pregnancy and gamma/delta T cells: taking on the hard questions. Reprod Biol Endocrinol (2003) 0.78
Oropharyngeal tularemia--a differential diagnosis of tonsillopharyngitis and cervical lymphadenitis. Wien Klin Wochenschr (2010) 0.78
Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccination. Clin Dev Immunol (2013) 0.75
Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. Nature (1995) 5.04
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science (1994) 3.90
Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis (1977) 3.51
Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. Immunity (1995) 3.12
Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33
Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands. Eur J Immunol (1990) 2.25
Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity (1999) 2.14
Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol (1996) 2.13
Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur J Immunol (1995) 2.05
Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol Lett (1990) 1.87
Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J Infect Dis (1990) 1.71
The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol (1997) 1.69
Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. J Immunol (1996) 1.60
Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur J Immunol (1993) 1.53
Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis. Chest (1992) 1.39
Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms. J Exp Med (1994) 1.32
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes. J Immunol (1997) 1.30
Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev (1997) 1.29
Diversity of Francisella tularensis antigens recognized by human T lymphocytes. Infect Immun (1990) 1.28
A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia. J Infect Dis (1984) 1.26
Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J Immunol Methods (1999) 1.25
Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. Immunology (1992) 1.24
Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun (1994) 1.22
In vivo and in vitro activation and expansion of gammadelta T cells during Listeria monocytogenes infection in humans. Infect Immun (1997) 1.17
Polyclonal expansion of peripheral gamma delta T cells in human Plasmodium falciparum malaria. Infect Immun (1994) 1.16
Time of lymphocyte response after onset of tularemia and after tularemia vaccination. J Clin Microbiol (1979) 1.14
Human TcR gamma delta+ lymphocyte response on primary exposure to Plasmodium falciparum. Clin Exp Immunol (1994) 1.14
Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis (1994) 1.13
Is T-cell priming required for initiation of pathology in malaria infections? Immunol Today (1999) 1.13
Gamma delta T cells and the immune response in visceral leishmaniasis. Eur J Immunol (1992) 1.12
Major expansion of gammadelta T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J Infect Dis (1999) 1.12
Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun (1998) 1.12
Predominant expansion of V gamma 9/V delta 2 T cells in a tularemia patient. Infect Immun (1992) 1.12
Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol (1990) 1.08
Issues concerning the nature of antigen recognition by alpha beta and gamma delta T-cell receptors. Immunol Today (1995) 1.03
Human gamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R. J Immunol (1996) 1.02
Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. J Clin Invest (1995) 0.99
Selective activation of resting human gamma delta T lymphocytes by interleukin-2. Eur J Immunol (1993) 0.95
Delayed expansion of V delta 2+ and V delta 1+ gamma delta T cells after acute Plasmodium falciparum and Plasmodium vivax malaria. J Allergy Clin Immunol (1996) 0.95
T cell subset analysis in peripheral blood of children with RSV bronchiolitis. Scand J Infect Dis (1998) 0.93
Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94- peripheral Vgamma9 Vdelta2 T cells but not on CD94- thymic or mature gammadelta T cell clones. Eur J Immunol (1998) 0.90
Different percentages of peripheral blood gamma delta + T cells in healthy individuals from different areas of the world. Scand J Immunol (1996) 0.88
The number and proportion of Vgamma9 Vdelta2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infection. Clin Infect Dis (1997) 0.81
Novel abnormality in subpopulations of circulating lymphocytes. T gamma delta and CD2-, 3+, 4-, 8- lymphocytes in histoplasmosis-associated immunodeficiency. Int Arch Allergy Appl Immunol (1989) 0.80
Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol (1994) 3.37
Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun (2001) 2.51
Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J Clin Microbiol (2000) 2.40
Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun (1997) 2.40
Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions. Infect Immun (1984) 2.37
A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun (1988) 2.34
Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol (2000) 2.31
Extensive allelic variation among Francisella tularensis strains in a short-sequence tandem repeat region. J Clin Microbiol (2001) 2.03
Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol (1997) 1.99
A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis (1993) 1.94
Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol Immunol (1992) 1.82
Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol (1985) 1.73
Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol (1987) 1.64
Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan. J Clin Microbiol (1992) 1.63
Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.54
A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes. Infect Immun (1984) 1.53
Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect Immun (1983) 1.52
Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis. J Immunol (1990) 1.50
CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun (1994) 1.50
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
Epidemiological analysis of tularemia in Sweden 1931-1993. FEMS Immunol Med Microbiol (1996) 1.46
Superoxide dismutase isozymes in different human tissues, their genetic control and intracellular localization. Hum Hered (1973) 1.45
Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1975) 1.42
Cytokine expression in the liver during the early phase of murine tularemia. Infect Immun (1995) 1.39
Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages. Infect Immun (2000) 1.39
Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. J Appl Microbiol (2001) 1.37
Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect Immun (1999) 1.36
Amplification and restriction endonuclease digestion of a large fragment of genes coding for rRNA as a rapid method for discrimination of closely related pathogenic bacteria. J Clin Microbiol (1996) 1.35
Isolation of lymphocytes from blood. A procedure combining nylon fibre filtration and differential centrifugation. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.32
Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect Immun (1994) 1.32
Use of RNA hybridization in the diagnosis of a case of ulceroglandular tularemia. Eur J Clin Microbiol Infect Dis (1990) 1.26
Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. Microb Comp Genomics (2000) 1.25
The T-cell-stimulating 17-kilodalton protein of Francisella tularensis LVS is a lipoprotein. Infect Immun (1991) 1.22
Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis (2011) 1.22
Autism associated with marker chromosome. J Am Acad Child Adolesc Psychiatry (1991) 1.22
Inhibition of PHA-induced lymphocyte stimulation by the pregnancy zone protein. FEBS Lett (1973) 1.21
Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection (1992) 1.21
Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man. Immunology (1992) 1.18
Specific detection of Coxiella burnetii through partial amplification of 23S rDNA. Eur J Epidemiol (1997) 1.18
Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1978) 1.17
Time of lymphocyte response after onset of tularemia and after tularemia vaccination. J Clin Microbiol (1979) 1.14
Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis (1994) 1.13
Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol Med Microbiol (1996) 1.13
Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun (1998) 1.12
Effect of amphotericin B and clotrimazole on lymphocyte stimulation. Antimicrob Agents Chemother (1974) 1.11
Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine. J Clin Microbiol (1985) 1.10
Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J (2000) 1.09
Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol (1990) 1.08
Influence of complement on the chemiluminescent response of human leukocytes to immune complex. Infect Immun (1980) 1.07
Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine (1999) 1.07
Demonstration of opsonizing antibodies to Francisella tularensis by leukocyte chemiluminescence. Infect Immun (1980) 1.05
Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell Death Dis (2011) 1.04
Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol Med Microbiol (1996) 1.03
Detection of antigen in urine of a patient with tularemia. Eur J Clin Microbiol (1987) 1.02
Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans. Immunology (1992) 1.00
Molecular cloning and expression of a T-cell stimulating membrane protein of Francisella tularensis. Microb Pathog (1989) 1.00
A case of tularemia meningitis in Sweden. Scand J Infect Dis (1990) 0.99
Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol (1998) 0.99
5-fluorocytosine treatment of candida infections of the urinary tract and other sites. Scand J Urol Nephrol (1972) 0.98
Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine (1995) 0.97
Inhibition of the mixed lymphocyte reaction by the pregnancy zone protein. FEBS Lett (1975) 0.96
Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components. Eur J Clin Microbiol Infect Dis (1991) 0.96
Molecular Detection of Persistent Francisella tularensis Subspecies holarctica in Natural Waters. Int J Microbiol (2010) 0.95
Transcriptional profiling of the peripheral blood response during tularemia. Genes Immun (2006) 0.95
Fixation of femoral neck fracture. A randomized 2-year follow-up study of hook pins and sliding screw plate in 222 patients. Acta Orthop Scand (1995) 0.95
Francisella tularensis: host-parasite interaction. FEMS Immunol Med Microbiol (1996) 0.93
Hospitalization due to Pasteurella multocida-infected animal bite wounds: correlation with inadequate primary antibiotic medication. Scand J Infect Dis (2000) 0.91
Prevalence of antibodies specific to Puumala virus among farmers in Sweden. Scand J Work Environ Health (1998) 0.89
Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. Res Microbiol (1991) 0.89
Early cytokine induction in mouse P388D1 macrophages infected by Coxiella burnetii. Vet Immunol Immunopathol (1999) 0.89
Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis (1997) 0.88
Local host response in the lower respiratory tract in nephropathia epidemica. Scand J Infect Dis (1993) 0.88
Anaerobic phagocytosis, killing, and degradation of Streptococcus pneumoniae by human peripheral blood leukocytes. Infect Immun (1985) 0.88
Ciprofloxacin for treatment of tularemia. Clin Infect Dis (2001) 0.88
Anaerobic meningitis in children. Eur J Clin Microbiol (1986) 0.87
Long-lasting recall response of CD4+ and CD8+ alphabeta T cells, but not gammadelta T cells, to heat shock proteins of francisella tularensis. Scand J Infect Dis (2001) 0.87
Zinc and immune function in Down's syndrome. Acta Paediatr Scand (1980) 0.87
Prevalence of serum antibodies to hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins. Scand J Infect Dis (1997) 0.87
Auditory perception in schizophrenia: a second study of the Intonation test. Acta Psychiatr Scand (1973) 0.86
Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome--relation to arterial hypotension and tumor necrosis factor. Infection (1997) 0.86
Detection of nephropathia epidemica virus RNA in patient samples using a nested primer-based polymerase chain reaction. J Infect Dis (1992) 0.86
Antigenic composition of a vaccine strain of Francisella tularensis. Int Arch Allergy Appl Immunol (1980) 0.85
Infrequent manifestations of tularaemia in Sweden. Scand J Infect Dis (1997) 0.85
Wound infections in general surgery. Wound contamination, rates of infection and some consequences. Acta Chir Scand (1976) 0.85
Transferable and non-transferable drug resistance in enteric bacteria isolated from urinary specimens in Northern Sweden. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.85
Lymphocyte response to phytohaemagglutinin following cholecystectomy. Acta Pathol Microbiol Scand (1969) 0.85